BISOPROLOL VIATRIS 5 mg, film-coated tablet scored 30 tablets, CIP 3400930184059
Active ingredients: Bisoprolol monofumarate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet scored30 tablets, CIP 3400930184059orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BISOPROLOL VIATRIS 5 mg, comprimé pelliculé sécable
- Pharmaceutical form
- comprimé pelliculé sécable
- Route of administration
- orale
- Presentation description
- 30 plaquette(s) PVC PVDC aluminium de 1 comprimé(s)
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 20 Jan 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a specialist
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64791577CIP73018405CIP133400930184059Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| HÉMIFUMARATE DE BISOPROLOLcomprimé | 5 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.